Healthequity Financials
| 2HE Stock | EUR 90.50 1.50 1.69% |
Healthequity |
Understanding current and past Healthequity Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Healthequity's financial statements are interrelated, with each one affecting the others. For example, an increase in Healthequity's assets may result in an increase in income on the income statement.
Healthequity Stock Summary
Healthequity competes with Veeva Systems, 10X GENOMICS, Teladoc, and Evolent Health. HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah. HealthEquity operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1141 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US42226A1079 |
| Business Address | 15 West Scenic |
| Sector | Technology |
| Industry | Health Information Services |
| Benchmark | Dow Jones Industrial |
| Website | www.healthequity.com |
| Phone | 801 727 1000 |
| Currency | EUR - Euro |
You should never invest in Healthequity without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Healthequity Stock, because this is throwing your money away. Analyzing the key information contained in Healthequity's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Healthequity Key Financial Ratios
There are many critical financial ratios that Healthequity's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Healthequity reports annually and quarterly.| Return On Equity | -0.0313 | |||
| Return On Asset | 0.0037 | |||
| Target Price | 85.5 | |||
| Beta | 0.77 | |||
| Z Score | 3.0 |
Healthequity Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Healthequity's current stock value. Our valuation model uses many indicators to compare Healthequity value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Healthequity competition to find correlations between indicators driving Healthequity's intrinsic value. More Info.Healthequity is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Healthequity's earnings, one of the primary drivers of an investment's value.Healthequity Systematic Risk
Healthequity's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Healthequity volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Healthequity correlated with the market. If Beta is less than 0 Healthequity generally moves in the opposite direction as compared to the market. If Healthequity Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Healthequity is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Healthequity is generally in the same direction as the market. If Beta > 1 Healthequity moves generally in the same direction as, but more than the movement of the benchmark.
Healthequity December 21, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Healthequity help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Healthequity. We use our internally-developed statistical techniques to arrive at the intrinsic value of Healthequity based on widely used predictive technical indicators. In general, we focus on analyzing Healthequity Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Healthequity's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.98 | |||
| Information Ratio | 0.1565 | |||
| Maximum Drawdown | 19.03 | |||
| Value At Risk | (2.58) | |||
| Potential Upside | 2.82 |
Complementary Tools for Healthequity Stock analysis
When running Healthequity's price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |